In hepatoma cells, depletion of SIRT7 SE induces H3K18 acetylation and reactivation of key metabolic and immune regulators, leading to significant suppression of tumorigenicity in vitro and in vivo. The gene discussed is SIRT7; the disease is hepatocellular carcinoma.